Source: BioPortfolio

ARMO BioSciences: ARMO Biosciences Inc ARMO Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12042018 Prices from USD $250

SummaryARMO Biosciences Inc ARMO Biosciences is an immunooncology company that develops tumors treatment drugs. The company develops antiprogrammed cell death protein 1 checkpoint inhibitors and other therapeutic cytokines. Its portfolio of pipeline drug c...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Peter Van Vlasselaer's photo - President & CEO of ARMO BioSciences

President & CEO

Peter Van Vlasselaer

CEO Approval Rating

93/100

Read more